Beaumont RCSI Cancer Centre

Momentous day for cancer clinic trials in Ireland as HRB announce €21 million investment

December 21, 2021 | Blog
Momentous day for cancer clinic trials in Ireland as HRB announce €21 million investment

Beaumont RCSI Cancer Centre have welcomed the €21 million investment in cancer clinical trials announced by the Health Research Board. The National Clinical Trial Network will be hosted by RCSI University of Medicine and Health Sciences led by Professor Ray McDermott (Chief Scientific Investigator, Cancer Trials Ireland).

Beaumont Hospital – RCSI University of Medicine and Health Sciences Cancer Trials Group led by Professor Patrick Morris and hosted at RCSI is one of six Cancer Clinical Trials Groups to receive funding as part of this momentous investment.

The HRB funding will tackle childhood and adult cancers, making a real difference to the lives of cancer patients, allowing them more access to cancer trials by increasing the resources and expertise required to conduct them. Click here for further information on the HRB announcement